<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Seropositivity following full-dose yellow fever (YF) vaccination in adults.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Study vaccine</th>
    <th rowspan="2">Population</th>
    <th rowspan="2">Type</th>
    <th rowspan="2">Test and seropositivity criteria</th>
    <th rowspan="2">Time post vaccination</th>
    <th colspan="2">Seropositive</th>
   </tr>
   <tr>
    <th>No.</th>
    <th>(%)</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>
     <p>Kareko 2019
      <sup>
       <xref ref-type="bibr" rid="CR27">27</xref>
      </sup>
     </p>
     <p>17D-204 (USA)</p>
    </td>
    <td>Non-endemic</td>
    <td>Obs</td>
    <td>
     <p>PRNT
      <sub>90</sub>
     </p>
     <p>Titer ≥ 10</p>
    </td>
    <td>
     <p>1m–61y</p>
     <p>
      <italic>0–3y</italic>
      <sup>
       <italic>a</italic>
      </sup>
     </p>
     <p>
      <italic>3–12y</italic>
     </p>
     <p>&gt;
      <italic>12y</italic>
     </p>
    </td>
    <td>
     <p>71/92</p>
     <p>
      <italic>12/13</italic>
     </p>
     <p>
      <italic>28/37</italic>
     </p>
     <p>
      <italic>22/32</italic>
     </p>
    </td>
    <td>
     <p>(77)</p>
     <p>(92)</p>
     <p>(76)</p>
     <p>(67)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Wieten 2016
      <sup>b </sup>
      <sup>
       <xref ref-type="bibr" rid="CR54">54</xref>
      </sup>
     </p>
     <p>17D-204 (Europe)</p>
    </td>
    <td>Non-endemic</td>
    <td>Obs</td>
    <td>
     <p>PRNT
      <sub>80</sub>
     </p>
     <p>IU/mL ≥ 0.5</p>
    </td>
    <td>
     <p>11–40y</p>
     <p>
      <italic>35–40y</italic>
      <sup>
       <italic>a</italic>
      </sup>
     </p>
    </td>
    <td>
     <p>89/99</p>
     <p>
      <italic>6/6</italic>
     </p>
    </td>
    <td>
     <p>(90)</p>
     <p>(100)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Collaborative Group 2014
      <sup>c </sup>
      <sup>
       <xref ref-type="bibr" rid="CR28">28</xref>
      </sup>
     </p>
     <p>17DD (Brazil)</p>
    </td>
    <td>Endemic</td>
    <td>Obs</td>
    <td>
     <p>PRNT
      <sub>50</sub>
     </p>
     <p>mIU/mL ≥ 794</p>
    </td>
    <td>
     <p>1m–12+y</p>
     <p>
      <italic>1–4y</italic>
      <sup>
       <italic>a</italic>
      </sup>
     </p>
     <p>
      <italic>5–9y</italic>
     </p>
     <p>
      <italic>10–11y</italic>
     </p>
     <p>≥
      <italic>12y</italic>
     </p>
    </td>
    <td>
     <p>561/651</p>
     <p>
      <italic>107/114</italic>
     </p>
     <p>
      <italic>69/83</italic>
     </p>
     <p>
      <italic>105/138</italic>
     </p>
     <p>
      <italic>163/191</italic>
     </p>
    </td>
    <td>
     <p>(86)</p>
     <p>(94)</p>
     <p>(83)</p>
     <p>(76)</p>
     <p>(85)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Campi-Azevedo 2019
      <sup>
       <xref ref-type="bibr" rid="CR30">30</xref>
      </sup>
     </p>
     <p>17DD (Brazil)</p>
    </td>
    <td>Endemic</td>
    <td>Obs</td>
    <td>
     <p>Micro-PRNT
      <sub>50</sub>
     </p>
     <p>Titer &gt; 50</p>
    </td>
    <td>
     <p>1m–10+y</p>
     <p>1m</p>
     <p>1–5y</p>
     <p>6–9y</p>
     <p>≥10y</p>
    </td>
    <td>
     <p>155/178</p>
     <p>48/50</p>
     <p>38/40</p>
     <p>30/33</p>
     <p>39/55</p>
    </td>
    <td>
     <p>(87)</p>
     <p>(96)</p>
     <p>(95)</p>
     <p>(90)</p>
     <p>(71)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Miyaji 2017
      <sup>d</sup>
      <sup>
       <xref ref-type="bibr" rid="CR31">31</xref>
      </sup>
     </p>
     <p>17DD (Brazil)</p>
    </td>
    <td>Endemic</td>
    <td>Obs</td>
    <td>
     <p>Micro-PRNT
      <sub>50</sub>
     </p>
     <p>mIU/mL ≥ 794</p>
    </td>
    <td>
     <p>≤10y</p>
     <p>&gt;10y</p>
    </td>
    <td>
     <p>64/70</p>
     <p>21/24</p>
    </td>
    <td>
     <p>(91)</p>
     <p>(88)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Lindsey 2018
      <sup>
       <xref ref-type="bibr" rid="CR56">56</xref>
      </sup>
     </p>
     <p>17D-204 (USA)</p>
    </td>
    <td>Non-endemic</td>
    <td>Obs</td>
    <td>
     <p>PRNT
      <sub>90</sub>
     </p>
     <p>Titer &gt; 10</p>
    </td>
    <td>
     <p>1m–53y</p>
     <p>
      <italic>0–4y</italic>
      <sup>
       <italic>a</italic>
      </sup>
     </p>
     <p>
      <italic>5–9y</italic>
     </p>
     <p>
      <italic>10–19y</italic>
     </p>
     <p>
      <italic>20–29y</italic>
     </p>
     <p>≥
      <italic>30y</italic>
     </p>
    </td>
    <td>
     <p>200/221</p>
     <p>
      <italic>128/136</italic>
     </p>
     <p>
      <italic>18/19</italic>
     </p>
     <p>
      <italic>34/42</italic>
     </p>
     <p>
      <italic>13/16</italic>
     </p>
     <p>
      <italic>7/8</italic>
     </p>
    </td>
    <td>
     <p>(90)</p>
     <p>(94)</p>
     <p>(95)</p>
     <p>(81)</p>
     <p>(81)</p>
     <p>(88)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Martins 2018
      <sup>e</sup>
      <sup>
       <xref ref-type="bibr" rid="CR32">32</xref>
      </sup>
     </p>
     <p>17DD (Brazil)</p>
    </td>
    <td>
     <p>Non-endemic</p>
     <p>region of Brazil</p>
    </td>
    <td>Obs</td>
    <td>
     <p>PRNT
      <sub>50</sub>
     </p>
     <p>mIU/mL ≥ 2.7 log
      <sub>10</sub>
     </p>
    </td>
    <td>
     <p>1m</p>
     <p>10m</p>
     <p>8y</p>
    </td>
    <td>
     <p>128/131</p>
     <p>115/117</p>
     <p>56/68
      <sup>f</sup>
     </p>
    </td>
    <td>
     <p>(97)</p>
     <p>(98)</p>
     <p>(82)</p>
    </td>
   </tr>
   <tr>
    <td>
     <p>Roukens 2018
      <sup>
       <xref ref-type="bibr" rid="CR57">57</xref>
      </sup>
     </p>
     <p>17D-204 (France)</p>
    </td>
    <td>Non-endemic</td>
    <td>Obs</td>
    <td>
     <p>PRNT
      <sub>80</sub>
     </p>
     <p>Titer ≥ 10</p>
    </td>
    <td>10y</td>
    <td>34/35</td>
    <td>(97)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>Obs</italic> observational, 
   <italic>PRNT</italic> plaque reduction neutralization test, 
   <italic>IU</italic> international units, 
   <italic>m</italic> months, 
   <italic>y</italic> years.
  </p>
  <p>
   <sup>a</sup>Data presented in italic are subsets of total.
  </p>
  <p>
   <sup>b</sup>Wieten et al
   <sup>
    <xref ref-type="bibr" rid="CR68">68</xref>
   </sup>. also published data on 30 healthy and 15 immunocompromised individuals vaccinated at median 9 years (range 0–22 years) and median 7 years (range 0–18 years) previously, respectively; it is not known if there is overlap between the healthy population and those included in the study in the table above. Antibody titers were detected (IU/mL ≥ 0.5) in 15/15 (100%) immunocompromised and 29/30 (97%) healthy individuals.
  </p>
  <p>
   <sup>c</sup>Data from vaccinees were presented in a separate paper using a lower cut-off of 2.7 mIU/mL for seropositivity. The proportion seropositive was higher for all groups: 99% seropositivity at 1–4 years post-vaccination; 88% seropositivity at 5–9 years; 86% seropositivity at 10–11 years; and 90% seropositivity at ≥12 years.
  </p>
  <p>
   <sup>d</sup>Cohort contained individuals who received one dose (
   <italic>n</italic> = 59); two or more doses (
   <italic>n</italic> = 17); or unknown number of doses (
   <italic>n</italic> = 18) of YF vaccine. Data not broken down by time post-vaccination and number of doses other than to note there was no difference in the seropositivity by time post-vaccination for those receiving one dose.
  </p>
  <p>
   <sup>e</sup>The 1-month and 10-month results data were obtained from original study paper by Martins et al. 2013
   <sup>
    <xref ref-type="bibr" rid="CR69">69</xref>
   </sup>. Only includes individuals who received a full dose of the vaccine.
  </p>
  <p>
   <sup>f</sup>Only includes persons who received full dose of YF vaccine and who were seropositive at 1-month and 10-month follow-up visits.
  </p>
 </table-wrap-foot>
</table-wrap>
